StonvexLoading…
StonvexStonvexStonvexCore line items from LHX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-02 | Annual 2025 2025-01-03 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $21.86B | $21.32B | $19.42B | $17.06B |
Operating Income | $2.11B | $1.92B | $1.43B | $1.13B |
Net Income | $1.61B | $1.50B | $1.23B | $1.06B |
EPS (Diluted) | $8.53 | $7.87 | $6.44 | $5.49 |
Total Assets | $41.20B | $42.00B | $41.69B | $33.52B |
Total Liabilities | $21.56B | $22.42B | $22.86B | $14.90B |
Cash & Equivalents | $1.07B | $615.00M | $560.00M | $880.00M |
Free Cash Flow OCF − CapEx | $2.68B | $2.15B | $1.65B | $1.91B |
Shares Outstanding | 186.84M | 189.79M | 189.81M | 190.61M |